SCHEMBL6982434

SCHEMBL6982434

O=C(O)CC1(c2ccc(Cl)cc2)OCC(c2ccccc2)(c2ccccc2)CO1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
HSD11B1 P28845 4/20 0.43
CNR1 P21554 1/20 0.40
EPHX2 P34913 1/20 0.39
TSHR P16473 1/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.37
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 1/20 0.34
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
CCR3 P51677 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
DRD2 P14416 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983251 0.84 GAA (0.47) ALDH1A1MAPTL3MBTL1
SCHEMBL7815962 0.80 OPRM1 (0.35) ALDH1A1HSD11B1KMT2AMAPTL3MBTL1
SCHEMBL6967893 0.78 CNR1 (0.40) ALDH1A1HSD11B1CNR1PTGDR2KMT2A
SCHEMBL11816794 0.76 HSD11B1 (0.43) ALDH1A1HSD11B1CNR1EPHX2KMT2A
SCHEMBL6977901 0.75 CNR1 (0.41) ALDH1A1CNR1EPHX2KMT2AMAPT
SCHEMBL6981407 0.74 CNR1 (0.37) ALDH1A1HSD11B1CNR1PTGDR2CES2
SCHEMBL377756 0.72 MAPK1 (0.40) ALDH1A1HSD11B1CNR1TSHRKMT2A
SCHEMBL6970913 0.72 OPRM1 (0.45) ALDH1A1KMT2AMAPTL3MBTL1
SCHEMBL6980629 0.70 APP (0.41) ALDH1A1KMT2ACYP1A2CYP2C19MAPT
SCHEMBL11806493 0.70 AKR1B1 (0.40) ALDH1A1HSD11B1CNR1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed